UBS raises Amgen price target to $470 from $430
UBS raised its Amgen price target to $470.00 per share from $430.00, according to Benzinga’s ratings-action recap.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
UBS Raises Amgen Price Target To $470 From $430
UBS Raises Amgen Price Target To $470 From $430